ArticleClinical kidney journal2025

Dipeptidyl peptidase 4 inhibitors reduce the risk of adverse outcomes after acute kidney injury in diabetic patients.

Hung-Wei Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.